Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.

Mina R, Mylin AK, Yokoyama H, Magen H, Alsdorf W, Shune L, Isufi I, Harrison SJ, Shah UA, De Champlain A, Katz EG, Gries KS, Schecter JM, Lendvai N, Slaughter A, Lonardi C, Deraedt W, Costa Filho O, Patel N, Florendo E, Ho KF, Karlin L, Weisel K

Open source

DOI: 10.1186/s41687-026-01034-z
Published: 2026 Mar 13
Container: Journal of patient-reported outcomes
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s41687-026-01034-z,
  title = {Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.},
  author = {Mina R and Mylin AK and Yokoyama H and Magen H and Alsdorf W and Shune L and Isufi I and Harrison SJ and Shah UA and De Champlain A and Katz EG and Gries KS and Schecter JM and Lendvai N and Slaughter A and Lonardi C and Deraedt W and Costa Filho O and Patel N and Florendo E and Ho KF and Karlin L and Weisel K},
  year = {2026},
  journal = {Journal of patient-reported outcomes},
  doi = {10.1186/s41687-026-01034-z},
  url = {https://doi.org/10.1186/s41687-026-01034-z}
}

RIS

TY  - JOUR
TI  - Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.
AU  - Mina R
AU  - Mylin AK
AU  - Yokoyama H
AU  - Magen H
AU  - Alsdorf W
AU  - Shune L
AU  - Isufi I
AU  - Harrison SJ
AU  - Shah UA
AU  - De Champlain A
AU  - Katz EG
AU  - Gries KS
AU  - Schecter JM
AU  - Lendvai N
AU  - Slaughter A
AU  - Lonardi C
AU  - Deraedt W
AU  - Costa Filho O
AU  - Patel N
AU  - Florendo E
AU  - Ho KF
AU  - Karlin L
AU  - Weisel K
PY  - 2026
JO  - Journal of patient-reported outcomes
DO  - 10.1186/s41687-026-01034-z
UR  - https://doi.org/10.1186/s41687-026-01034-z
ER  -

APA

R, M., AK, M., H, Y., H, M., W, A., L, S., I, I., SJ, H., UA, S., A, D. C., EG, K., KS, G., JM, S., N, L., A, S., C, L., W, D., O, C. F., N, P., E, F., KF, H., L, K., & K, W. (2026). Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.. Journal of patient-reported outcomes. https://doi.org/10.1186/s41687-026-01034-z

Source records

pubmed · retrieved 2026-09-26T19:16:51.283Z